The focus of research at RB&HSD is in the frontier areas of radiation biology for understanding the effect of low- and high LET radiations, chronic and acute radiation exposure, high background radiation, and radionuclide exposure on mammalian cells, cancer cells, experimental rodents and human health.
Preclinical and translational research is aimed at development of new drugs and therapeutics for prevention and mitigation of radiation injury, de-corporation of heavy metals and treatment of inflammatory disorders and cancers.
We are also studying macromolecular structures and protein-ligand interactions using biophysical techniques like X-ray crystallography, neutron-scattering, circular dichroism and synchrotron radiation, with an aim for ab initio design of therapeutic molecules.
11/2020With Dr. Anu Ghosh
With Dr. Mukesh Kumar
With Dr. Mukesh Kumar
With Dr. Mukesh Kumar
With Dr. B. N. Pandey
With Dr. B. N. Pandey
With Dr. Bhavani Shankar
With Dr. S. Santosh Kumar & Dr. B. N. Pandey
With Dr. S. Santosh Kumar, Dr. B. N. Pandey & Dr. Bhavani Shankar
With Dr. S. Santosh Kumar & Dr. B. N. Pandey
With Dr. S. Santosh Kumar
With Dr. S. Santosh Kumar and Dr. Bhavani Shankar
With Dr. S. Santosh Kumar
With Dr. S. Santosh Kumar
With Dr. B. N. Pandey
With Dr. B. N. Pandey
The technology on “Bio-Engineering of Lectin Based Radioprotector” was incubated with M/S Gennova Biopharmaceutics, Pune on 31st March, 2017 for manufacturing of BRP based therapeutic formulation and its new variants under GMP conditions and conducting clinical trials.
Technology on “Development of Radioprotector Drug Formulation” was incubated with M/S IDRS Labs Pvt Ltd, Bengaluru on 10th July 2015 for making tablets of BRM under GMP conditions. This MoU was extended in Feb 2017 for conducting clinical trials.
Development of novel therapeutics for mitigation of radiation toxicity, cancer and immune disorders
High level area of Kerala coast
Animal House Facility
Protein crystallography research for understanding biology at molecular level
Understanding tumor immune interaction for development of novel cancer therapeutics
Understanding radiation induced bystander effects and biological effects of Th-232
Biological and molecular effects of ionizing radiation
